Kevin Jerome Madden

Kevin Jerome Madden
Partner

John Hancock Tower

Boston, MA 02116

kmadden@mofo.com

(617) 648-4741

BAR ADMISSIONS

Massachusetts

EDUCATION

Bates College, B.A.

American University Washington College of Law, J.D.

Kevin J. Madden is a partner in the firm’s Boston office.

Kevin advises private equity and venture capital investors and public and private company clients on a broad range of transactions, including mergers and acquisitions, leveraged buyouts, growth and venture investments, and divestitures.

He represents clients operating in a range of industries including technology, life sciences, health care, food and agriculture, and manufacturing.

Prior to joining Morrison & Foerster, Kevin practiced in the Boston office of another international law firm, where he advised private equity sponsors and public and private companies on corporate and transactional matters.

Experience

Separation and IPO of Centuri

Southwest Gas Holdings and Centuri, a former wholly owned subsidiary of Southwest Gas Holdings, in the separation and initial public offering of Centuri.

Examinetics's Investment by Coalesce Capital

Represented Examinetics in an inaugural investment by Coalesce Capital, a private equity firm focused on business services.

Ethos Capital’s Acquisition of Donuts, Inc.

Represented Ethos Capital in its majority control acquisition of Donuts, Inc. Named a Mergers & Acquisitions 2022 Deal of the Year.

Alpine Investors and TEAM Services Group's Acquisitions

Represented Alpine Investors and its portfolio company TEAM Services Group in the acquisitions of 24 Hr Homecare, Pearl’s Hope, Inteli-Care, We Care, and a division of HealthStar Home Health.

Alpine Investors and Trilon Group's Partnerships and Acquisitions

Represented Alpine Investors and its portfolio company Trilon Group in the partnership with CPH and Alta Planning + Design, Horrocks Engineering as well as acquisitions of Waggoner Engineering, DRMP, ESI Consultants, Ramey Kemp, The Mannik & Smith Group, CME Associates, Gonzalez Companies, Fehr-Graham and Wilson Engineers.

Lyons Magnus's Acquisition of Phillips Syrups and Sauces

Represented Lyons Magnus, a leader in the food service industry, in its acquisition of Phillips Syrups and Sauces, an Ohio-based business that designs, manufactures, sells and distributes coffee house products, ice cream shop products and breakfast syrups.

Honey Birdette’s Acquisition by PLBY Group, Inc.

Represented Honey Birdette, the fast-growing, luxury lingerie and lifestyle brand, and its sellers, in the USD333 million sale to PLBY Group, Inc. (Nasdaq: PLBY), a leading pleasure and leisure lifestyle company and owner of Playboy.

American Healthcare Investors’ Acquisition by Griffin-American Healthcare REIT III

Represented American Healthcare Investors on the anticipated acquisition of its business by Griffin-American Healthcare REIT III, a healthcare-focused real estate investment trust.

LIVEKINDLY Collective’s Joint Venture with RCL Foods

Represented LIVEKINDLY Collective, a collection of heritage and startup brands on track to become one of the world’s largest plant-based food companies, on the commercial and intellectual property aspects of its establishment, together with RCL Foods, of a plant-based joint venture, LIVEKINDLY Collective Africa.

NorthBridge Partners’ Final Close of its Fund III, LP

Represented Boston-based NorthBridge Partners on the final close of NB Partners Fund III, LP. NorthBridge launched Fund III in March 2020, together with Park Madison Partners, a New York-based capital and advisory firm focused on the global real estate alternative investments industry

Greenlane Holdings’ Agreed Merger with KushCo Holdings

Represented Greenlane Holdings, Inc. (Nasdaq: GNLN), a global house of brands and one of the largest sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, in its agreement to merge with KushCo Holdings, Inc. (OTCQX: KSHB).

Temasek’s Joint Venture with Bayer

Represented Temasek Holdings Pte Ltd. in connection with a joint venture with Bayer to create Unfold Bio, Inc., a new venture to focus on innovation in vegetable varieties with the goal of lifting the vertical farming space to the next level of quality, efficiency and sustainability. We also assisted Temasek in the initial Series A financing and negotiation of a licensing agreement between Bayer and Unfold Bio.

Abry Partners’ Sale of Music Reports Inc.

Represented Abry Partners, a leading Boston-based private equity firm, in connection with the sale of its portfolio company, Music Reports Inc., to MidOcean Partners, a New York-based alternative middle market private equity asset manager.

Palo Alto Networks’ Acquisition of Zingbox

Represented Palo Alto Networks, an internet and software security company, in its acquisition of Zingbox, an IoT cybersecurity company.

Klein Tools’ Acquisition of Ergodyne

Represented Klein Tools, manufacturer of professional grade tools and related equipment for tradespeople, in its acquisition of Ergodyne, maker of safety work gear, from its parent company Tenacious Holdings.

N2 Biomedical’s Sale to Ampersand Capital Partners

Represented the equity holders of N2 Biomedical, a provider of coating and surface treatment for medical and dental applications, in its sale to Ampersand Capital Partners, a Boston-based private equity firm.

Sale of Gerawan Farming to Wawona Packing

Represented an individual seller in his sale of Gerawan Farming, a family peach farming business, to Wawona Packing Co., a fruit and packing company that is backed by Paine Schwartz, a private equity firm.

Brahmin’s Sale to Markel Corporation

Represented the equity holders of Brahmin, the maker of high quality leather accessories, in its sale to Markel Corporation.

Seajoy Seafood Corporation

Represented Seajoy Seafood Corporation, one of the largest vertically integrated shrimp farming businesses in Central and South America, in its sale to Cooke Aquaculture.

Private Equity Firm’s Mergers and Sales

Represented a Boston-based private equity firm and its portfolio companies in buy-side (including leveraged buy- outs) and sell-side mergers, stock and asset sales transactions, including cross-border transactions, valued between $15 million to $950 million.

A Private Equity Firm’s Acquisitions

Represented a New York-based private equity firm in connection with two acquisitions in the food manufacturing and services business.

Sale of a Homecare Nursing Company

Represented a national homecare nursing company in connection with its sale.

Searchers’ Fund Formation and Acquisitions

Represented searchers in the formation of search funds and fundraising, acquisitions, and ongoing corporate matters.

Sale of a Data Analytics Company

Represented a data analytics company in its sale to a clinical trial SaaS company.

An Online Backup Services Company’s Strategic Transaction

Represented an online backup services company in a strategic transaction.

Sale of an Internet and Healthcare Company

Represented an internet and healthcare company in its sale to a global health services company.

Sale of a Long-Term Care Pharmacy

Represented a long-term care pharmacy in its sale to a strategic acquirer.

Sale of a Dermatology Practice

Represented a dermatology practice in its sale to a portfolio company of a U.S.-based private equity fund.

A Major Cloud Computing Company’s Acquisition

Represented a major cloud computing company in the acquisition of companies in various countries, valued between $5 million and $500 million.

Investments by Generation Investment Management

Represented Generation Investment Management’s investments in Weka, Elation Health and AlayaCare.

Freedom 3 Capital's Investment

Represented Freedom 3 Capital in its investments in a grocery distributor, medical coding and training company, and a collectibles business.

Phesi’s Investment from Sensyne Health

Represented Phesi, a data-driven provider of AI-powered clinical development analytics products and solutions for biopharmaceutical companies, in securing a $10 million investment from Sensyne Health (LSE: SENS), a clinical AI technology company, as part of an exclusive strategic collaboration.

Preferred Equity Financing

Represented multiple venture-backed technology, health care, and life science companies and investors in preferred equity financings.

Rankings

Legal 500 US 2022

Ranked Practice: M&A / Corporate and Commercial: Private Equity Buyouts

Mergers & Acquisitions 2022

Deal of the Year, Team Member

Law360 2021

Private Equity Practice Group of the Year